Displaying drugs 851 - 875 of 2800 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Alprazolam | 308.765 C17H13ClN4 |  | A triazolobenzodiazepine with intermediate onset commonly used to treat panic disorders and generalized anxiety in addition to anxiety associated with depression. | Anti-Anxiety Agents |
| Phthalylsulfathiazole | 403.43 C17H13N3O5S2 |  | A sulfonamide antibacterial indicated in the treatment of gastrointestinal infections. | Sulfonamides |
| Lesinurad | 404.28 C17H14BrN3O2S |  | A uric acid 1 transporter inhibitor typically used in combination with a xanthine oxidase inhibitor to treat hyperuricemia associated with gout in patients with inadequate control of uric acid levels with xanthine oxidase inhibitor monotherapy. | Preparations Increasing Uric Acid Excretion |
| Roflumilast | 403.207 C17H14Cl2F2N2O3 |  | A selective phosphodiesterase-4 inhibitor indicated to decrease the risk of exacerbations in patients with severe chronic obstructive pulmonary disease (COPD) and to treat skin conditions such as plaque psoriasis and atopic dermatitis. | Phosphodiesterase 4 Inhibitors |
| Celecoxib | 381.372 C17H14F3N3O2S |  | An NSAID used to treat osteoarthritis, rheumatoid arthritis, acute pain, menstrual symptoms, and to reduce polyps is familial adenomatous polyposis. | COX-2 Inhibitors / Sulfonamides |
| Rosoxacin | 294.3047 C17H14N2O3 |  | For the treatment of bacterial infection of respiratory tract, urinary tract, GI, CNS and immuno compromised patients. | Anti-Infective Agents |
| Rofecoxib | 314.356 C17H14O4S |  | A COX-2 inhibitor NSAID used to treat osteoarthritis, rheumatoid arthritis, acute pain, primary dysmenorrhea, and migraine attacks. | COX-2 Inhibitors / Selective Cyclooxygenase 2 Inhibitors (NSAIDs) |
| Selumetinib | 457.68 C17H15BrClFN4O3 |  | A MEK 1/2 inhibitor used in pediatric patients to treat neurofibromatosis type 1 (NF1) accompanied by symptomatic, inoperable plexiform neurofibromas (PN). | Mitogen-activated protein kinase (MEK) inhibitors |
| Binimetinib | 441.233 C17H15BrF2N4O3 |  | A medication used to treat metastatic melanoma with specific mutations. | Mitogen-activated protein kinase (MEK) inhibitors / Protein Kinase Inhibitors |
| Fenofibric acid | 318.75 C17H15ClO4 |  | A fibrate used to treat severe hypertriglyceridemia, primary hypercholesterolemia, or mixed dyslipidemia. | Fibric Acids |
| Tedizolid | 370.344 C17H15FN6O3 |  | An oxazolidinone class antibiotic that inhibits bacterial protein synthesis and is proven to be effective in the treatment of certain Gram-positive bacterial infections. | Anti-Bacterial Agents / Oxazolidinone Antibacterial |
| Balsalazide | 357.3175 C17H15N3O6 |  | An aminosalicylate used to treat ulcerative colitis. | Salicylates |
| Zaleplon | 305.3339 C17H15N5O |  | A sedative used for short term treatment of insomnia in adults. | Anticonvulsants / GABA Modulators / gamma-Aminobutyric Acid A Receptor Agonist |
| Benorilate | 313.309 C17H15NO5 |  | Not Annotated | Salicylic Acid and Derivatives |
| Amoxapine | 313.781 C17H16ClN3O |  | A tricyclic antidepressant used in the treatment of neurotic or reactive depressive disorders and endogenous or psychotic depression. | Non-Selective Monoamine Reuptake Inhibitors |
| Asenapine | 285.77 C17H16ClNO |  | An atypical antipsychotic used to treat patients with bipolar I disorder and patients with schizophrenia. | Diazepines, Oxazepines, Thiazepines and Oxepines |
| Mefloquine | 378.3122 C17H16F6N2O |  | An antimalarial agent used in the prophylaxis and treatment of malaria caused by Plasmodium falciparum and Plasmodium vivax. | Antimalarial methanolquinolines |
| Vonoprazan | 345.39 C17H16FN3O2S |  | A potassium-competitive acid blocker used in the treatment of acid-related disorders and as an adjunct to Helicobacter pylori eradication. | Alimentary Tract and Metabolism / Amides / Cytochrome P-450 CYP2B6 Substrates / Cytochrome P-450 CYP2C19 Inhibitors / Cytochrome P-450 CYP2C19 inhibitors (strength unknown) / Cytochrome P-450 CYP2C19 Substrates / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP2D6 Substrates / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A5 Substrates / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Drugs for Acid Related Disorders / Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord) / Gastric Acid Lowering Agents / P-glycoprotein inhibitors / Potassium-competitive Acid Blockers / Sulfones / Sulfur Compounds |
| Tedizolid phosphate | 450.323 C17H16FN6O6P |  | An oxazolidinone class antibiotic that inhibits bacterial protein synthesis and is proven to be effective in the treatment of certain Gram-positive bacterial infections. | Anti-Bacterial Agents / Oxazolidinone Antibacterial |
| Eslicarbazepine acetate | 296.326 C17H16N2O3 |  | An anticonvulsant agent used as an adjunct to treat partial-onset seizures in patients with inadequate clinical response to conventional antiepileptic therapy. | Carboxamide Derivatives |
| Sertraline | 306.23 C17H17Cl2N |  | A selective serotonin reuptake inhibitor (SSRI) indicated to treat major depressive disorder, social anxiety disorder and many other psychiatric conditions. | Antidepressive Agents Indicated for Depression / Drugs causing inadvertant photosensitivity / Selective Serotonin Reuptake Inhibitors / Serotonin Modulators |
| Eszopiclone | 388.808 C17H17ClN6O3 |  | A sedative-hypnotic used in the treatment of insomnia, improving both the latency phase and the maintenance phase of sleep. | Drugs causing inadvertant photosensitivity / Piperazines / Pyrazines / Pyridines |
| Zopiclone | 388.808 C17H17ClN6O3 |  | A nonbenzodiazepine hypnotic used for the short-term management of insomnia. | Drugs causing inadvertant photosensitivity / Sleep Initiation and Maintenance Disorders |
| Griseofulvin | 352.766 C17H17ClO6 |  | An antifungal agent used to treat a variety of superficial tinea infections and fungal infections of the fingernails and toes. | Antifungals for Systemic Use |
| Cefapirin | 423.463 C17H17N3O6S2 |  | A first generation cephalosporin indicated in the treatment of susceptible bacterial infections. | Anti-Bacterial Agents / First-Generation Cephalosporins |
Displaying drugs 851 - 875 of 2800 in total